Medinol Ltd - Product Pipeline Analysis, 2017 Update

Summary

Medinol Ltd (Medinol) is a medical device company that develops, manufactures, and inspects stents and delivery systems. The companys products comprise stents, bare metal stents, catheters, spring tip stents, elastomer based drug eluting stents, cobalt chrome alloy stents, individual stents, and vessel conformability and scaffolding stents. Its other products comprise low crossing profile stents, endeavor stents, driver stents, PTCA balloon catheter, patented catheter, biliary metallic stents, superior and traditional tube-based stents, radiopaque markers, and others. Medinol offers services such as research and development, coating, quality control, regulatory affairs, clinical trials and studies, drug elution, inherently brittle, traditional polymer coating services, and others. The company operates in Tel Aviv and Jerusalem, Israel. Medinol is headquartered in Tel Aviv, Israel.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Medinol Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Medinol Ltd Company Overview 4
Medinol Ltd Company Snapshot 4
Medinol Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Medinol Ltd Pipeline Analysis Overview 7
Medinol Ltd - Key Facts 7
Medinol Ltd - Major Products and Services 8
Medinol Ltd Pipeline Products by Development Stage 10
Medinol Ltd Ongoing Clinical Trials by Trial Status 12
Medinol Ltd Pipeline Products Overview 14
ChampioNIR Dual-Component Peripheral Stent 14
ChampioNIR Dual-Component Peripheral Stent Product Overview 14
Elunir Elastomer Drug Eluting Stent 15
Elunir Elastomer Drug Eluting Stent Product Overview 15
Elunir Elastomer Drug Eluting Stent Clinical Trial 16
Gallant PTCA Balloon Catheter 18
Gallant PTCA Balloon Catheter Product Overview 18
Medinol Ltd - Key Competitors 19
Medinol Ltd - Key Employees 20
Medinol Ltd - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Medinol Ltd, Recent Developments 22
Feb 16, 2017: Medinol Announces Appointment Of Harvey J. Berger, M.D., As Executive Chairman Of Medinol US 22
Dec 21, 2016: Medinol announces excellent clinical results for EluNIR, a novel Drug Eluting Stent 22
Nov 07, 2016: Medinol receives approval from the Japanese PMDA to begin clinical study on novel DES 23
May 17, 2016: Medinol Announces Outstanding Results in a Randomized Trial of a New Drug Eluting Stent 23
Mar 21, 2016: NIRTRAKS Study of a Novel Coronary Stent Enrolls Its First Patient 24
Dec 01, 2015: Medinol U.S. Commercializes Novel Coronary Stent 25
Sep 22, 2015: Medinol Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES Coronary Stent System 25
Jan 14, 2014: ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease 26
Apr 12, 2012: Medinol Receives FDA Clearance For Presillion Plus CoCr Coronary Stent On RX System 26
Jan 11, 2011: Boston Scientific Reaches Settlement With Medinol 27
Appendix 28
Methodology 28
About GlobalData 30
Contact Us 30
Disclaimer 30

List Of Tables


Medinol Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Medinol Ltd Pipeline Products by Equipment Type 5
Medinol Ltd Pipeline Products by Indication 6
Medinol Ltd Ongoing Clinical Trials by Trial Status 6
Medinol Ltd, Key Facts 7
Medinol Ltd, Major Products and Services 8
Medinol Ltd Number of Pipeline Products by Development Stage 10
Medinol Ltd Pipeline Products Summary by Development Stage 11
Medinol Ltd Ongoing Clinical Trials by Trial Status 12
Medinol Ltd Ongoing Clinical Trials Summary 13
ChampioNIR Dual-Component Peripheral Stent - Product Status 14
ChampioNIR Dual-Component Peripheral Stent - Product Description 14
Elunir Elastomer Drug Eluting Stent - Product Status 15
Elunir Elastomer Drug Eluting Stent - Product Description 15
Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) EUropean Angiography Study 16
Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis - PK Study 16
Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) in Coronary Stenosis Trial 16
Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) in Coronary Stenosis Trial 16
Elunir Elastomer Drug Eluting Stent - Japanese Regulatory Approval Clinical Study of EluNIR Elastomer Drug Eluting Stent 17
Elunir Elastomer Drug Eluting Stent - Multi-center Study for Evaluating the Safety and Efficacy of the MedJ-01 Ridaforolimus Eluting Coronary Stent System (MedJ-01) In Coronary Stenosis Trial 17
Gallant PTCA Balloon Catheter - Product Status 18
Gallant PTCA Balloon Catheter - Product Description 18
Medinol Ltd, Key Employees 20
Medinol Ltd, Other Locations 21
Glossary 29

List Of Figures


Burmeister & Wain Scandinavian Contractor A/S, Power, Deals By Year, 2011 to YTD 2017 22
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals by Type, 2011 to YTD 2017 23

Medinol Ltd - Product Pipeline Analysis, 2018 Update

Medinol Ltd (Medinol) is a medical device company that researches, develops and manufactures cardiovascular intervention solutions. The companys products include coronary stent system, bare metal stents, PTCA dilatation catheter, biliary

USD 750 View Report

Medinol Ltd - Product Pipeline Analysis, 2017 Update

Medinol Ltd (Medinol) is a medical device company that develops, manufactures, and inspects stents and delivery systems. The companys products comprise stents, bare metal stents, catheters, spring tip stents, elastomer

USD 750 View Report

Namibia Power Corporation (Proprietary) Ltd - Strategic SWOT Analysis Review

Namibia Power Corporation (Proprietary) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT

USD 125 View Report

Godrej & Boyce Mfg Co Ltd - Strategic SWOT Analysis Review

Godrej & Boyce Mfg Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available